Where burping appears in each document
The US label for Rybelsus® is shared with Ozempic® tablets, a newer semaglutide tablet line in 1.5, 4 and 9 mg strengths. The safety section explains that its numbers come from trials of Rybelsus® and apply to both products [1]. Canada’s monograph covers both formulations too [3], while Europe now markets the newer strengths under the Rybelsus® name, up to 50 mg [2].
| Document | Trial pool | What it reports |
|---|---|---|
| US Prescribing Information, section 6.1 [1] | Two placebo-controlled trials in type 2 diabetes | 14 mg 2%, 7 mg 0.6%, placebo 0%; listed in the text below Table 2 |
| Canadian Product Monograph, Table 3 [3] | PIONEER 1 (26 weeks) and PIONEER 8 (52 weeks) | 14 mg 2.0%, 7 mg 0.6%, placebo 0 |
| EU summary of product characteristics, section 4.8 [2] | Pooled phase 3a trials, heart outcomes trial excluded | Uncommon: from 1 in 1,000 up to 1 in 100 |
| EU and Canadian patient leaflets [2][3] | Plain-language lists | “Burping” under uncommon side effects |
Why 2% in one place and “uncommon” in another
The figures are not in conflict; they describe different groups of patients. The US and Canadian tables come from just two placebo-controlled trials, which makes the comparison with placebo clean but the sample small: 356 people per tablet strength [1][3]. The European band is calculated across the pooled phase 3a programme, in which 5,707 people took semaglutide alongside several comparator drugs, and it places burping below 1 in 100 [2].
Two features stand out in the tablet data. Nobody on placebo reported burping, so even a small percentage is a real difference. And it was more frequent on 14 mg than on 7 mg, a pattern also seen with overall stomach reactions, which rose from 21% on placebo to 32% on 7 mg and 41% on 14 mg [1]. The Canadian monograph adds that stomach events were more frequent in women and in people with a lower body mass index, groups who had higher blood levels of semaglutide [3].
What drug-safety reports show
Adverse-event databases collect voluntary reports from patients and clinicians. They can show that a symptom is reported more often with one medicine than with others, but they cannot give a rate or prove cause, and well-known effects tend to be reported more.
A 2024 analysis of the US FDA reporting system looked only at semaglutide tablets, covering 2,398 reports from the third quarter of 2019 to the third quarter of 2023. Burping was one of the strongest stomach signals: 35 reports, with a reporting odds ratio of about 26, meaning it was reported far more often with the tablets than with other medicines in the database [4]. An earlier analysis of all semaglutide reports, injections and tablets together, found burping had the highest signal of 45 stomach-related terms [5]. So burping is not unique to the tablet form; it belongs to the molecule.
Why semaglutide may bring more burping
- Supported by the label: semaglutide slows stomach emptying, and the tablet label lists stomach reactions that include burping, indigestion, reflux and a swollen belly [1].
- Plausible but not measured: MedlinePlus explains that burping happens when air builds up in the upper stomach and stretches it, and that reflux disease is one cause of abnormal burping [6]. Reflux was also reported more often on the tablets than on placebo [1], but no study has tested whether the two travel together on Rybelsus®.
- General knowledge: everyone swallows some air with food and drink, and people typically burp up to 30 times a day, according to NIDDK [7].
Other reasons for burping
NIDDK and MedlinePlus list causes that have nothing to do with a diabetes tablet [6][7]:
- Swallowing more air, for example by chewing gum, sucking hard sweets, drinking fizzy drinks, smoking or wearing loose dentures.
- Swallowing air without noticing (aerophagia), which can lead to burping before the air even reaches the stomach.
- Gastroesophageal reflux disease and other digestive conditions.
- Eating quickly, and certain foods and drinks that produce gas.
Steps general sources describe
MedlinePlus suggests lying on your side or in a knee-to-chest position until the gas passes, and avoiding chewing gum, eating quickly and gas-producing foods and drinks [6]. NIDDK lists ways to swallow less air: skipping fizzy drinks and straws, not talking while eating, eating more slowly and sitting down for meals; a clinician may also suggest smaller, more frequent meals [8].
Rybelsus® already limits what you drink at the moment you take it. The label asks for the tablet on an empty stomach in the morning with up to 4 ounces (about 120 mL) of plain water, nothing else, and a wait of at least 30 minutes before food, drinks or other tablets [1]. More water or a shorter wait lowers how much semaglutide is absorbed [1][3], so these rules are not something to adjust on your own to ease burping.
Details specific to the tablet
Rybelsus® is a once-daily tablet for adults with type 2 diabetes. It contains an absorption enhancer called salcaprozate sodium (SNAC), and most absorption happens in the stomach [1]. The label does not say whether the enhancer plays any part in stomach symptoms, and burping is also reported by people using semaglutide injections [5].
The US starting step is 3 mg for 30 days, a strength the label says does not control blood sugar but is meant to reduce stomach side effects, before moving to 7 mg and then possibly 14 mg [1]. Logging when burping starts relative to these steps gives your prescriber something concrete to look at.
Rybelsus® and Ozempic® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| A swollen face, lips, tongue or throat, difficulty breathing or swallowing, or fainting | Emergency services; stop the tablets | Emergency | Rybelsus® Medication Guide [1] |
| Severe stomach pain that does not go away, sometimes reaching the back, with or without vomiting | Stop the tablets and call your prescriber right away | Emergency | Rybelsus® Medication Guide [1] |
| Pain in the upper stomach with fever, yellow skin or eyes, or clay-coloured stools | Your prescriber, right away | Today | Rybelsus® Medication Guide [1] |
| Burping that does not go away, or that comes with belly pain or fever | A health care provider | At your next appointment | MedlinePlus [6] |
| Severe or lingering stomach problems | Your prescriber | Today | Rybelsus® Medication Guide [1] |
| Gas or burping with constipation, diarrhoea or unplanned weight loss, or burping that simply bothers you | Your doctor, at the next appointment | At your next appointment | NIDDK [7] |
